000282920 001__ 282920
000282920 005__ 20251218103446.0
000282920 0247_ $$2doi$$a10.5281/ZENODO.14510099
000282920 0247_ $$2doi$$a10.5281/zenodo.14510099
000282920 037__ $$aDZNE-2025-01381
000282920 1001_ $$0P:(DE-2719)9001970$$aHampton Leonard$$b0
000282920 245__ $$aDataset: Global Parkinson's Genetics Program Data Release 9, v4
000282920 260__ $$bZenodo$$c2024
000282920 3367_ $$2BibTeX$$aMISC
000282920 3367_ $$0PUB:(DE-HGF)32$$2PUB:(DE-HGF)$$aDataset$$bdataset$$mdataset$$s1765985087_5350
000282920 3367_ $$026$$2EndNote$$aChart or Table
000282920 3367_ $$2DataCite$$aDataset
000282920 3367_ $$2ORCID$$aDATA_SET
000282920 3367_ $$2DINI$$aResearchData
000282920 520__ $$aIn December 2024, GP2 announced the 9th data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PD. This release includes 17,690 additional genotyped participants. The genotype array data, including locally-restricted samples, now consists of a total of 71,835 genotyped participants (31,985 PD cases, 18,249 Controls, and 21,601 ‘Other’ phenotypes) When removing the locally-restricted samples, these now consist of 55,305 samples (23,709 PD cases, 13,404 Controls, and 18,192 ‘Other’ phenotypes) Of those 71,835 samples with genotyped data: 16,800 individuals also have deep clinical phenotyping information (Release 8) 10,454 total individuals also have clinical exomes information (Release 8) 7,732 total individuals also have WGS data (Release 8) Please see the accompanying blog for further description of this release. To obtain data access, please see https://amp-pd.org/researchers/data-use-agreement. For any publications using data from this release, please reference the DOI number and the following statement: 'Data (DOI 10.5281/zenodo.14510099, release 9) and/or code used in the preparation of this article were obtained from Global Parkinson’s Genetics Program (GP2). GP2 is funded by the Aligning Science Across Parkinson’s (ASAP) initiative and implemented by The Michael J. Fox Foundation for Parkinson’s Research (https://gp2.org). For a complete list of GP2 members see https://gp2.org.'
000282920 536__ $$0G:(DE-HGF)POF4-354$$a354 - Disease Prevention and Healthy Aging (POF4-354)$$cPOF4-354$$fPOF IV$$x0
000282920 588__ $$aDataset connected to DataCite
000282920 7001_ $$aMike Nalls$$b1
000282920 7001_ $$aDan Vitale$$b2
000282920 7001_ $$aMathew Koretsky$$b3
000282920 7001_ $$aKristin Levine$$b4
000282920 7001_ $$aMary Makarious$$b5
000282920 7001_ $$0P:(DE-2719)9001362$$aFang, Zih-Hua$$b6$$udzne
000282920 7001_ $$aJones, Lietsel$$b7
000282920 7001_ $$aSolle, J.$$b8
000282920 773__ $$a10.5281/zenodo.14510099
000282920 7870_ $$0DZNE-2024-01334$$aLeonard, Hampton et.al.$$dZenodo, 2023$$iRelatedTo$$r$$tDataset: Global Parkinson's Genetics Program Data Release 5, v1
000282920 909CO $$ooai:pub.dzne.de:282920$$pVDB
000282920 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001362$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000282920 9131_ $$0G:(DE-HGF)POF4-354$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Prevention and Healthy Aging$$x0
000282920 9201_ $$0I:(DE-2719)1210002$$kAG Heutink$$lGenome Biology of Neurodegenerative Diseases$$x0
000282920 980__ $$adataset
000282920 980__ $$aVDB
000282920 980__ $$aI:(DE-2719)1210002
000282920 980__ $$aUNRESTRICTED